Abstract
In the early part of the twentieth century, through the work of Alexis Carrel and others, it was quite well established that allografts of organs such as skin or kidney would function for a time but after one or two weeks the graft would be lost. In the 1940s Medawar and colleagues established clearly the immunological basis of allograft rejection. That allografts might not always be incompatible was suggested by Owen who found that “freemartin” bovine dizygotic twins had a mixture of red blood types from each partner. It remained for Billingham, Brent and Medawar to show that donor specific tolerance could be induced by injection of donor cells into newborn mice. The exciting early days of transplantation immunology are described in detail in the 1960 monograph of Woodruff [1], written near the time of action, and the 1997 monograph of Brent [2], written with the clarity made possible by the passage of three decades.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Woodruff MFA (1960) The Transplantation of Tissues and Organs. Charles C. Thomas, Springfield, Illinois
Brent L (1997) A History of Transplantation Immunology. Academic Press, San Diego
Jacobson LO, Simmons EL, Marks ËK, Eldredge JH (1951) Recovery from radiation injury. Science 113: 510–511
Lorenz E, Uphoff D, Reid TR, Shelton E (1951) Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 12:197–201
Main JM, Prehn RT (1955) Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst 15:1023–1029
Ford CE, Hamerton JL, Barnes DWH, Loutit JF (1956) Cytological identification of radiation-chimaeras. Nature 177:452–454
Barnes DWH, Loutit JF (1957) Treatment of murine leukaemia with x-rays and homologous bone marrow: II. Br J Haematol 3: 241–252
Thomas ED, Lochte HL, Jr., Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257:491–496
Thomas ED, Lochte HL, Jr., Cannon JH, Sahler OD, Ferrebee JW (1959) Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 38:1709–1716
Mathe G, Amiel JL, Schwarzenberg L, Catton A, Schneider M (1965) Adoptive immunotherapy of acute leukemia: Experimental and clinical results. Cancer Res 25:1525–1531
Epstein RB, Storb R, Ragde H, Thomas ED (1968) Cytotoxic typing antisera for marrow grafting in littermate dogs. Transplantation 6: 45–58
Storb R, Epstein RB, Ragde H, Thomas ED (1968) Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing. Transplantation 6: 587–593
Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA (1968) Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet ii: 1366–1369
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone-marrow transplantation. N Engl J Med 292: 832–843, 895–902
Thomas ED, Flournoy N, Buckner CD, Clift RA, Fefer A, Neiman PE, Storb R (1977) Cure of leukemia by marrow transplantation. Leuk Res 1: 67–70
Bone Marrow Donors Worldwide (BMDW) (1998) http://bmdw.leidenuniv.nl. (UnPub)
Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C (1998) Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338:962–968
Mannick JA, Lochte HL, Jr., Ashley CA, Thomas ED, Ferrebee JW (1960) Autografts of bone marrow in dogs after lethal total-body radiation. Blood 15: 255–266
Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC, Jr., Jones R, Shpall E, Wu K, Rosner G, Gilbert C, Mathias B, Coniglio D, Petros W, Henderson IC, Norton L, Weiss RB, Budman D, Hurd D (1993) High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132–1143
Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallogan J, Berenson RJ (1994) Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12: 28–36
Horowitz MM (1998) Uses and growth of hematopoietic cell transplantation. In: Thomas ED, Forman SJ, Blume KG (eds) Hematopoietic Cell Transplantation. Blackwell Science, Boston, in press.
Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet ii: 580–585
Juttner CA, To LB, Ho JQK, Thorp DL, Kimber RJ (1987) Successful peripheral blood stem-cell autograft with a near-critical dose of myeloid progenitor cells in acute non-lymphoblastic leukaemia in relapse. Med J Aust 147: 292–293
Korbling M, Drach J, Champlin RE, Engel H, Huynh L, Kleine HD, Berenson R, Deisseroth AB, Andreeff M (1994) Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR-hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and flourescence-activated cell sorting: implications for gene transduction and/or transplantation. Bone Marrow Transplant 13: 649–654
Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, Flowers M, Sullivan KM, Witherspoon RP, Rowley SD, Hansen JA, Storb R, Appelbaum FR (1997) Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90: 4705–4709
Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurtzberg J, Bard J, Boyse EA (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174–1178
Rubinstein P, Dobrila L, Rosenfield RE, Adams on JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE (1995) Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 92:10119–10122
Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte J-P, Fernandez M, Chastang C (1997) Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 337:373–381
Williams D (1998) Methods for gene transfer. Genetic manipulation of hematopoietic stem cells. In: Thomas ED, Forman SJ, Blume KG (eds) Hematopoietic Cell Transplantation. Blackwell Science, Boston, in press.
Dunbar C (1998) Gene marking. In: Thomas ED, Forman SJ, Blume KG (eds) Hematopoietic Cell Transplantation. Blackwell Science, Boston, in press.
Billingham RE, Brent L (1959) Quantitative studies on tissue transplantation immunity. IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease. Philos Trans R Soc Lond B Biol Sci 242: 477
Thomas ED, Buckner CD, Gift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL (1979) Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301: 597–599
Storb R, Deeg HJ, Whitehead J, Farewell V, Appelbaum FR, Beatty P, Bensinger W, Buckner CD, Gift R, Doney K, Hansen J, Hill R, Lum LG, Martin P, McGuffin R, Sanders JE, Singer J, Stewart P, Sullivan KM, Witherspoon RP, Thomas ED (1987) Marrow transplantation for leukemia and aplastic anemia: Two controlled trials of a combination of methotrexate and cyclosporine versus cyclosporine alone or methotrexate alone for prophylaxis of acute graft-versus-host disease. Transplant Proc 19: 2608–2613
Martin PJ, Kernan NA (1990) T-cell depletion for the prevention of graft-vs.-host disease. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds) Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment. Marcel Dekker, New York, pp 371–387
Blazar BR, Korngold R, Vallera D (1997) Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev 157:109
van Bekkum DW (1993) BMT in experimental autoimmune diseases. Bone Marrow Transplant 11:183–187
Marmont AM (1994) Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases. Stem Cells 12:125–135
Ikehara S (1998) Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment (Review). Int J Mol Med 1:5–16
Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, Leisenring W, Shulman H (1997) Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89: 3048–3054
Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P, O’Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, Korbling M, Keating M, Kantarjian H, Champlin R (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 89:4531–4536
Mannick JA, Lochte HL, Jr., Ashley CA, Thomas ED, Ferrebee JW (1959) A functioning kidney homotransplant in the dog. Surgery 46: 821–828
Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49:511–533
Appelbaum FR, Dahlberg S, Thomas ED, Buckner CD, Cheever MA, Clift RA, Crowley J, Deeg HJ, Fefer A, Greenberg P, Kadin M, Smith W, Stewart P, Sullivan K, Storb R, Weiden P (1984) Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia - A prospective comparison. Ann Intern Med 101: 581–588
Meyers JD, Wade JC, Mitchell CD, Sarai R, Leitman PS, Durack DT, Levin M J, Segreti AC, Balfour HH, Jr. (1982) Multicenter collaborative trial of intravenous acyclovir for the treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med 73: 229–235
Zaia JA (1994) Cytomegalovirus infection. In: Forman SJ, Blume KG, Thomas ED (eds) Bone Marrow Transplantation. Blackwell Scientific Publications, Boston, MA, pp 376–403
Amylon MD, Co JP, Snyder DS, Donaldson SS, Blume KG, Forman SJ (1997) Allogeneic bone marrow transplantation in pediatric patients with high-risk hematopoietic malignancies early in the course of their disease. J Pediatr Hematol Oncol 19: 54–61
Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O’Donnell MR, Parker PM, Stein AS, et al. (1991) Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 78(8): 1923–1927
Saarinen UM, Meilander L, Nysom K, Ringden O, Schroeder H, Glomstein A, Gustafsson G, Nordic Society for Pediatric Hematology and Oncology (NOPHO) (1996) Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Bone Marrow Transplant 17: 357–363
Blume KG (1998) Allogeneic transplantation for acute myeloid leukemia in adults. In: Thomas ED, Forman SJ, Blume KG (eds) Hematopoietic Cell Transplantation. Blackwell Science, Boston, in press
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Thomas, E.D. (2000). Hematopoietic Cell Transplantation: The First 50 Years and a Glimpse of the Future. In: Berdel, W.E., et al. Transplantation in Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59592-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-59592-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64041-4
Online ISBN: 978-3-642-59592-9
eBook Packages: Springer Book Archive